In this study we investigated whether κ-opioid receptor stimulation by dynorphin A (1-13), a potent fragment of endogenous peptide, attenuated repeated stress-induced behavioral impairments in mice. In order to reduce the motivation to escape, mice were preexposed to inescapable electric footshock (day 0), and then dynorphin A (1-13) was administered to mice prior to the stress from the next day for 4 d (days 1-4). Dynorphin A (1-13) (1500 pmol/5 µL intracerebroventricular (i.c.v.)) attenuated the repeated stress-induced escape failures from the shock, and this improvement was inhibited by the pretreatment of nor-binaltorphimine (4.9 nmol/kg subcutaneously (s.c.)), a κ-opioid receptor antagonist. In the neurochemical experiments, we detected an increase in 5-hydroxyindoleacetic acid (5-HIAA) content, but not in serotonin (5-HT) content, and an increase in the 5-HIAA/5-HT ratio was observed in the amygdala of the group with footshock compared with the group without shock. Additionally, the changes in 5-HIAA content and the ratio were reversed by dynorphin A (1-13). However, there were no differences in 5-HT or 5-HIAA content or their ratios in the hippocampus among the three groups. These results suggest that dynorphin might alleviate the stress-induced behavioral impairments accompanied by regulation of the 5-HTergic system in the brain.Key words dynorphin; κ-opioid receptor; repeated stress; amygdala; serotonin The number of patients presenting with stress-induced behavioral abnormality is increasing in Japan as well as other developed countries, and thus it is very important to find a cure. Stress-induced behavioral abnormality in rodent is widely employed as a model of mood disorders.1) In the paradigm adopted in this study, i.e., the learned helplessness task, exposure to an uncontrollable aversive stimulus leads to a decreased ability to escape from subsequent aversive situations. Pre-exposure to inescapable electric footshock stress leads to a high escape failure rate in subsequent learning trials. This model is being used increasingly to investigate the neurobiology of affective illness and to explore candidates for medicines that relieve stress, 2) such as antidepressants which activate serotonergic system. In addition, many studies have revealed that the amygdala/hippocampus as well as the frontal cortex play a critical role in controlling such repeated aversive stress directly and/or indirectly.3,4) Therefore, we focus on the serotonergic system in the amygdala/hippocampus.Opioid systems in the brain are known to control mood function and pain.5) Opioid peptides and their receptors are found at high concentrations in regions of the limbic system. However, their involvement in the pathogenesis of mood disorders, particularly depressive illness, remains an enigma. Accumulating evidence from animal research has revealed that μ-, δ-, and κ-opioid receptors distinctly control mood-related processes. Delta-opioid receptor agonists show promise as antidepressants, whereas μ-opioid receptor agonists are charac...